Gene · 10399
RACK1: receptor for activated C kinase 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. RACK1: receptor for activated C kinase 1. Genes, record 10399. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/10399
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P63244 | Small ribosomal subunit protein RACK1 | 317 | 191 | Ensembl, GeneID, HGNC |
Source UniProt
Patents61
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 12545636 B2 | 2026-02-10 | 34 | P63244 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 14987 | P63244 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 7343 | P63244 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 14987 | P63244 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 7343 | P63244 | Espacenet |
| US 12215068 B2 | 2025-02-04 | 34 | P63244 | Espacenet |
| JP 2024534697 A | 2024-09-20 | 34 | P63244 | Espacenet |
| JP 2024533865 A | 2024-09-12 | 34 | P63244 | Espacenet |
| US 11773061 B2 | 2023-10-03 | 34 | P63244 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 36842 | P63244 | Espacenet |
1 to 10 of 61
See all 61 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,893
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RACK1 papers | Newest fiscal year |
|---|---|---|---|
| R01AI127456 | Poxvirus manipulation of the host cell protein synthesis machinery | 11 | 2025 |
| P30CA013148 | Comprehensive Cancer Center Support Grant | 8 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| ZIAHD000412 | Molecular Regulation Of RNA Metabolism | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| P30EY011373 | CWRU NEI Vision Center Core Grant | 4 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 4 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 3 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 3 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 1,893Source NIH's project files
See all 1,893 nih grantsPapers3,110
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential analysis of urinary stable downregulated proteins in male patients after colorectal cancer surgery. | Front Oncol | 2026 | 42707234 | PubTator, text mining | PubMed |
| Whole-transcriptome sequencing analysis to identify key non-coding RNAs in the pathogenesis of pulmonary tuberculosis. | Public Health Action | 2026 | 42639598 | PubTator, text mining | PubMed |
| Exploring the Association Between Rheumatoid Arthritis and Parkinson's Disease: Evidence from 2001-2016 NHANES, Real-World Clinical Data and Bioinformatics Analysis. | J Inflamm Res | 2026 | 42572743 | PubTator, text mining | PubMed |
| Targeting GEM Reprograms Macrophages and Overcomes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma. | Cancer Res | 2026 | 42561099 | PubTator, text mining | PubMed |
| RACK1 in host immune response to infections: molecular mechanisms and therapeutic potentials. | Front Immunol | 2026 | 42421949 | PubTator, text mining | PubMed |
| SEPTIN7 Enhances Tumorigenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling. | Cancer Res | 2026 | 42406998 | PubTator, text mining | PubMed |
| Correction: Molecular mechanisms of RACK1-driven metastasis in pancreatic ductal adenocarcinoma revealed by single-cell RNA sequencing. | Discov Oncol | 2026 | 42360598 | PubTator, text mining | PubMed |
| PKCβII Activation Promotes Membrane-Proximal Enrichment of Ribosome-Bound RACK1. | Int J Mol Sci | 2026 | 42353031 | PubTator, text mining | PubMed |
| Systems biology and single-cell transcriptome analysis identify potential therapeutic targets and impaired neurogenesis in human cortical development related to autism spectrum disorder. | Mol Divers | 2026 | 42319587 | PubTator, text mining | PubMed |
| RACK1 governs a dual metabolic switch in lung adenocarcinoma through c-Src/G6PD and TRIM21/LDHA Axes. | Cell Death Dis | 2026 | 42215440 | PubTator, text mining | PubMed |
1 to 10 of 3,110
See all 3,110 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/10399
GET https://conductscience.org/api/genes/v1/10399/patents?page=2